Research Partnership expands with appointment of five new market researchers
We are delighted to welcome five new market researchers to our London headquarters.
Alice Bardaux joins us as Research Executive. Alice has a Master’s degree in Marketing and Project Management from Skema Business School and has worked in market research, both client and agency side, for over 3 years in France and Mexico. Alice previously worked as a market research executive for Genatics and brings with her expertise in oncology and rare diseases. As part of our annual graduate trainee programme we also welcome our second intake of 4 new graduate researchers. Joining us are; Russell Collier a graduate in Biomedical Science from the University of Reading, Katy Huzzey has a degree in Biology from the University of Bath, Bérangère Pate joins us on a six month placement whilst undertaking her master’s degree in Market Research and Consulting at Montpellier University, and Ben Swannell who gained a BA in history and an MA in Medieval History from UCL.
Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?
Books espousing behavioural economic theories, such as “Thinking Fast and Slow” authored by Daniel Kahneman, have become essential reading for market researchers looking to improve their understanding of how people think, feel and behave.
This theory can be very useful in consumer research, where we already know the power brands have on influencing purchase decisions. But can behavioural economics theory be applied to the pharmaceutical healthcare industry, where treatment decisions are often made in a highly regulated environment and by educated professionals using sound, rational judgement?
An overview of the six most-commonly researched, largest pharmaceutical markets in Latin America
Dr Moniola Olusanjo appointed Compliance Manager
Research Partnership is delighted to welcome Dr Moniola Olusanjo to the company’s London headquarters in the role of Compliance Manager.
As part of Research Partnership’s ongoing industry commitment to compliance, Moniola’s appointment expands the company’s existing compliance capabilities and the role will encompass working with existing regional compliance officers to oversee compliance requirements for the company across all six offices globally.As Compliance Manager, Moniola will seek to continually improve and develop existing procedures, ensure that all 120 researchers training is complete and up-to-date, ensuring that Research Partnership adheres to all client, governmental and regional legal and ethical requirements globally. She will also act as client and industry liaison to ensure Research Partnership abides by and meets requirements, as well as to keep abreast of evolving initiatives and advancements within the pharmaceutical market research compliance industry.
Uncovering hidden insights into patient compliance
Pharma companies are increasingly looking for ways to provide “beyond the pill" services to support patients with the management of their disease. Adherence tools and programs encourage patients to stay compliant with their treatment regimen. But assessing compliance can be difficult with traditional methods giving biased results. Would the use of digital techniques elicit greater insights?